Targeting the PI3K/AKT/mTOR pathway in squamous cell carcinoma of the head and neck

DR Simpson, LK Mell, EEW Cohen - Oral oncology, 2015 - Elsevier
Despite recent advances in novel therapies, the prognosis for patients with squamous cell
carcinoma of the head and neck (SCCHN) remains poor. Progress in understanding the …
被引用次数：173 相关文章

Targeting the PI3K/AKT/mTOR pathway in squamous cell carcinoma of the head and neck

DR Simpson, LK Mell, EEW Cohen - Oral Oncology, 2015 - infona.pl
Despite recent advances in novel therapies, the prognosis for patients with squamous cell
carcinoma of the head and neck (SCCHN) remains poor. Progress in understanding the …

[引用][C] Targeting the PI3K/AKT/mTOR pathway in squamous cell carcinoma of the head and neck

DR Simpson, LK Mell, EEW Cohen - Oral Oncology, 2015 - cir.nii.ac.jp

Targeting the PI3K/AKT/mTOR pathway in squamous cell carcinoma of the head and neck

DR Simpson, LK Mell, EEW Cohen - Oral Oncology, 2015 - escholarship.org
Despite recent advances in novel therapies, the prognosis for patients with squamous cell
carcinoma of the head and neck (SCCHN) remains poor. Progress in understanding the …

Targeting the PI3K/AKT/mTOR pathway in squamous cell carcinoma of the head and neck.

DR Simpson, LK Mell, EE Cohen - Oral Oncology, 2014 - europepmc.org
Despite recent advances in novel therapies, the prognosis for patients with squamous cell
carcinoma of the head and neck (SCCHN) remains poor. Progress in understanding the …

Targeting the PI3K/AKT/mTOR pathway in squamous cell carcinoma of the head and neck

DR Simpson, LK Mell, EEW Cohen - Oral oncology, 2015 - pubmed.ncbi.nlm.nih.gov
Despite recent advances in novel therapies, the prognosis for patients with squamous cell
carcinoma of the head and neck (SCCHN) remains poor. Progress in understanding the …

Targeting the PI3K/AKT/mTOR pathway in squamous cell carcinoma of the head and neck

DR Simpson, LK Mell, EEW Cohen - Oral Oncology, 2015 - infona.pl
Despite recent advances in novel therapies, the prognosis for patients with squamous cell
carcinoma of the head and neck (SCCHN) remains poor. Progress in understanding the …